TY - JOUR
T1 - Risk factors for readmission following esophagectomy and gastrectomy for cancer
AU - Geerts, J. F. M.
AU - van den Berg, I
AU - van Nistelrooij, A. M. J.
AU - Lagarde, S. M.
AU - Wijnhoven, B. P. L.
N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus.
PY - 2025/1/1
Y1 - 2025/1/1
N2 - ntroduction:Hospital readmission after surgery is a key quality indicator. This nationwide cohortstudy aimed to assess readmission rates following esophagectomy and gastrectomy for cancer and identifyassociated risk factors.Methods:Data were extracted from the Dutch Upper GI Cancer Audit (DUCA) forpatients with esophagogastric cancer who underwent esophagectomy or gastrectomy with curative intent betweenJanuary 2011 and June 2016. Logistic regression analysis identified risk factors for 30-day readmission.Results:In total, 5566 patients were included. Readmission within 30 days occurred in 483 of 3488 (13.8%) patients afteresophagectomy and 243 of 2078 patients (11.7%) after gastrectomy. Both minor (Clavien Dindo 1-2) and major(Clavien Dindo >= 3) postoperative complications were independent predictors of readmission after esophagectomy(OR 2.99; 95%CI 2.23-4.02;p<0.001 and OR 5.20; 95%CI 3.82-7.09;p<0.001). Specific complications includedpulmonary (OR 1.49; 95%CI 1.20-1.85;p<0.001), gastrointestinal (OR 2.43; 95%CI 1.94-3.05;p<0.001),and infectious (OR 2.27; 95%CI 1.60-3.22;p<0.001). Prolonged length of stay (pLOS) was associated withhigher readmission rates in patients without complications following esophagectomy (OR 1.91 95% CI 1.19-3.07;p=0.008), but lower rates in those with complications (OR 0.65 95% CI 0.51-0.83;p<0.001). For gastrectomy, postoperative complications were also linked to readmission (OR 3.18; 95%CI 2.30-4.40;p<0.001), particularly gastrointestinal (OR 2.16; 95%CI 1.40-3.32;p<0.001), and infectious (OR 3.80; 95%CI 2.53-5.71;p<0.001).Conclusion: Readmission after esophagogastric resection is common, particularly among patients with both minorand major postoperative complications. Prolonged stay after esophagectomy impacts readmission risk differently based on the presence of complications.
AB - ntroduction:Hospital readmission after surgery is a key quality indicator. This nationwide cohortstudy aimed to assess readmission rates following esophagectomy and gastrectomy for cancer and identifyassociated risk factors.Methods:Data were extracted from the Dutch Upper GI Cancer Audit (DUCA) forpatients with esophagogastric cancer who underwent esophagectomy or gastrectomy with curative intent betweenJanuary 2011 and June 2016. Logistic regression analysis identified risk factors for 30-day readmission.Results:In total, 5566 patients were included. Readmission within 30 days occurred in 483 of 3488 (13.8%) patients afteresophagectomy and 243 of 2078 patients (11.7%) after gastrectomy. Both minor (Clavien Dindo 1-2) and major(Clavien Dindo >= 3) postoperative complications were independent predictors of readmission after esophagectomy(OR 2.99; 95%CI 2.23-4.02;p<0.001 and OR 5.20; 95%CI 3.82-7.09;p<0.001). Specific complications includedpulmonary (OR 1.49; 95%CI 1.20-1.85;p<0.001), gastrointestinal (OR 2.43; 95%CI 1.94-3.05;p<0.001),and infectious (OR 2.27; 95%CI 1.60-3.22;p<0.001). Prolonged length of stay (pLOS) was associated withhigher readmission rates in patients without complications following esophagectomy (OR 1.91 95% CI 1.19-3.07;p=0.008), but lower rates in those with complications (OR 0.65 95% CI 0.51-0.83;p<0.001). For gastrectomy, postoperative complications were also linked to readmission (OR 3.18; 95%CI 2.30-4.40;p<0.001), particularly gastrointestinal (OR 2.16; 95%CI 1.40-3.32;p<0.001), and infectious (OR 3.80; 95%CI 2.53-5.71;p<0.001).Conclusion: Readmission after esophagogastric resection is common, particularly among patients with both minorand major postoperative complications. Prolonged stay after esophagectomy impacts readmission risk differently based on the presence of complications.
UR - https://www.scopus.com/pages/publications/85214678832
U2 - 10.1093/dote/doae101
DO - 10.1093/dote/doae101
M3 - Article
C2 - 39550626
SN - 1120-8694
VL - 38
JO - Diseases of the Esophagus
JF - Diseases of the Esophagus
IS - 1
M1 - doae101
ER -
